156 related articles for article (PubMed ID: 24317815)
1. The association between cytotoxic T lymphocyte-associated antigen-4 and cervical cancer.
Liu P; Xu L; Sun Y; Wang Z
Tumour Biol; 2014 Apr; 35(4):2893-903. PubMed ID: 24317815
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
Zhu CL; Huang Q; Liu CH; Xie F
Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.
Xia W; Shi R; Zheng WL; Ma WL
Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis.
Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of the association between CTLA-4 +49 A/G, -318 C/T, and IL-1 polymorphisms and susceptibility to cervical cancer.
Lee YH; Song GG
Neoplasma; 2014; 61(4):481-90. PubMed ID: 24712845
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X
Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045
[TBL] [Abstract][Full Text] [Related]
7. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: the relationship between CTLA-4 +49 A/G polymorphism and primary biliary cirrhosis and type I autoimmune hepatitis.
Eskandari-Nasab E; Tahmasebi A; Hashemi M
Immunol Invest; 2015; 44(4):331-48. PubMed ID: 25942345
[TBL] [Abstract][Full Text] [Related]
9. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
10. Associations Between Three CTLA-4 Polymorphisms and Hashimoto's Thyroiditis Risk: An Updated Meta-Analysis with Trial Sequential Analysis.
Hu Y; Xu K; Jiang L; Zhang L; Shi H; Cui D
Genet Test Mol Biomarkers; 2018 Apr; 22(4):224-236. PubMed ID: 29461867
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 +49 A/G Polymorphism and the Risk of Lung Cancer: a Meta-analysis.
Wei Z; Zhang S; Hu J
Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):173-181. PubMed ID: 33819967
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.
Xiong YH; He L; Fei J
Int Immunopharmacol; 2014 Jan; 18(1):71-6. PubMed ID: 24201079
[TBL] [Abstract][Full Text] [Related]
14. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
[TBL] [Abstract][Full Text] [Related]
15. Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.
Geng R; Song F; Yang X; Sun P; Hu J; Zhu C; Zhu B; Fan W
Tumour Biol; 2014 Apr; 35(4):3627-39. PubMed ID: 24307627
[TBL] [Abstract][Full Text] [Related]
16. Association between cytotoxic T-lymphocyte-associated antigen 4 +49A/G polymorphism and persistent hepatitis B virus infection in the Asian population: evidence from the current studies.
Huang R; Hao Y; Fan Y; Yang C; Wu K; Cao S; Wu C
Genet Test Mol Biomarkers; 2013 Aug; 17(8):601-6. PubMed ID: 23725008
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk.
Zhao HY; Duan HX; Gu Y
Clin Transl Oncol; 2014 Oct; 16(10):879-85. PubMed ID: 24493286
[TBL] [Abstract][Full Text] [Related]
18. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
Gunesacar R; Erken E; Dinkci S
Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
[TBL] [Abstract][Full Text] [Related]
19. [Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer].
Li H; Zhou YF; Guo HY; Sun T; Zhang WH; Lin DX
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):681-4. PubMed ID: 22340049
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis.
Chang HY; Liu CY; Lo YL; Chiou SH; Lu KH; Lee MC; Wang YH
J Chin Med Assoc; 2023 Feb; 86(2):207-219. PubMed ID: 36652567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]